Envestnet Portfolio Solutions Inc. Sells 1,532 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Envestnet Portfolio Solutions Inc. cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,340 shares of the medical equipment provider’s stock after selling 1,532 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Intuitive Surgical were worth $20,012,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of ISRG. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at $31,000. Finally, MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the third quarter worth about $33,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research analyst reports. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Truist Financial boosted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Finally, Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last quarter. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $484.44 on Monday. The stock has a 50-day moving average of $567.46 and a two-hundred day moving average of $531.94. The stock has a market cap of $172.55 billion, a P/E ratio of 75.58, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.